PSY13 Opioid Substitution Treatment/Methadone

Description

PHCY320 (Psychiatry) Quiz on PSY13 Opioid Substitution Treatment/Methadone, created by Mer Scott on 14/10/2019.
Mer Scott
Quiz by Mer Scott, updated more than 1 year ago
Mer Scott
Created by Mer Scott about 5 years ago
4
0

Resource summary

Question 1

Question
Aims of OST​ - Opioid Substitution Treatment (OST) (formerly known as: Methadone Maintenance Treatment (MMT) ​ -reduce or cease [blank_start]illicit[blank_end] opioid use​ - reduce risk of [blank_start]blood-borne diseases[blank_end] transmitted by injecting​ - reduce risk of [blank_start]overdose[blank_end]​ - reduce rates of substance-related [blank_start]crime[blank_end]​ - support the client, family and whānau through recovery and [blank_start]access[blank_end] to support systems​
Answer
  • illicit
  • blood-borne diseases
  • overdose
  • crime
  • access

Question 2

Question
Methadone: - A [blank_start]synthetic[blank_end] opioid agonist​ - In NZ, Controlled Drug class [blank_start]B3[blank_end] ​ - Commonly prescribed for moderate to severe pain and treatment of opioid dependence​ - Long elimination half-life of [blank_start]15 – 60[blank_end] hours has been reported (Medsafe), therefore with repeated administration, doses have to be [blank_start]adjusted[blank_end] carefully​ - Takes [blank_start]5 - 6 days[blank_end] to reach steady state and thereafter may still need dose adjusting​ - Common side effects include a [blank_start]dry[blank_end] mouth, constipation, [blank_start]drowsiness, dizziness, nausea, vomiting,[blank_end] dental problems..​
Answer
  • synthetic
  • B3
  • 15 – 60
  • adjusted
  • 5 - 6 days
  • dry
  • drowsiness, dizziness, nausea, vomiting,

Question 3

Question
Methadone is the fifth most dispensed drug.
Answer
  • True
  • False

Question 4

Question
Misuse of Drugs Act 1975 Section 24​: Who can rx methadone: - Prescribers in an authorised methadone maintenance treatment clinic (e.g. Specialist Addiction Services SAS)​ - Individual GPs authorised in [blank_start]writing[blank_end] by a specific prescriber in a gazetted treatment service - Emergency treatment for dependence in [blank_start]hospital[blank_end] and not exceeding [blank_start]3 days[blank_end]​
Answer
  • writing
  • hospital
  • 3 days

Question 5

Question
When dispensing methadone, it needs to be prescribed on a Controlled drug H572/H572M prescription form.​
Answer
  • True
  • False

Question 6

Question
It is recommended that methadone be kept in a locked safe at all times, but not required.
Answer
  • True
  • False

Question 7

Question
[blank_start]Suboxone[blank_end] - a combination of buprenorphine and naloxone​. Class [blank_start]C4[blank_end] Controlled Drug​. Buprenorphine is an [blank_start]agoinist at 2 opioid receptors[blank_end]: µ (mu) opioid receptor partial agonist, and (kappa) opioid receptor antagonist. Naloxone is an [blank_start]antagonist at opioid receptors[blank_end]:t µ (mu), δ (delta) and ĸ (kappa) opioid receptors​ Naloxone is a deterrent. - Does not -need- [blank_start]triplicate[blank_end] form (unlike methadone) - No Controlled Drugs [blank_start]register[blank_end]​ (unlike methadone) - Must be kept in a locked safe at all times​.
Answer
  • C4
  • Suboxone
  • agoinist at 2 opioid receptors
  • antagonist at opioid receptors
  • triplicate
  • register

Question 8

Question
Suboxone and methodone combo = [blank_start]Biodone[blank_end] ​. - 3 strengths – 2mg/ml, 5mg/ml (Forte) ​and 10mg/ml (Extra Forte)​ - Orange, clear and pink​.
Answer
  • Biodone

Question 9

Question
Pharmacists’ responsibilities​ [blank_start]Confidential[blank_end] service reducing stigma​ Comply with all [blank_start]legislative[blank_end] requirements for OST dispensing, recording and storage of medicines​ [blank_start]SOP[blank_end] and auditable systems to minimise risk and errors​ Ensure adequate [blank_start]supervision[blank_end] of the consumption of OST doses​ Liaise with OST providers on a regular basis​ When would a pharmacist liase with the OST provider?​ Missed collecting more than [blank_start]one[blank_end] dose​ Presented [blank_start]intoxicated[blank_end]​ Abusive or [blank_start]threatening[blank_end] behaviour​ Diversion of dose (refers to the [blank_start]selling or exchanging[blank_end] of prescribed opioid substitution medication)​ [blank_start]Withdrawal[blank_end] symptoms​ Deteriorates in physical, emotional and mental state (potentially increased injecting behaviour)​ Pregnant?​
Answer
  • Confidential
  • legislative
  • SOP
  • supervision
  • one
  • intoxicated
  • threatening
  • selling or exchanging
  • Withdrawal

Question 10

Question
Needle Exchange programme: - IVDU is a [blank_start]health[blank_end] issue not criminal - Harm reduction; reduce [blank_start]HIV, HEP C[blank_end] disease spread - Needle Exchanges do [blank_start]not[blank_end] cause increase drug use​
Answer
  • health
  • HIV, HEP C
  • not
Show full summary Hide full summary

Similar

Mental health chapter 10
nursing fairy
Mental State Exam
Matthew Coulson
Perinatal Psychiatry
Matthew Coulson
Psychiatry Genetics
Matthew Coulson
Eating Disorders
Matthew Coulson
Neurobiology of Addiction
Matthew Coulson
Addictive behaviour
Megan Kerr
Behavioral Neuroscience
Tambriell Caudill
Introduction to Psychology
Skye Chen
Liaison Psychiatry
Vishnu Pradeep
Perinatal Psychiatry
Kit Grissett